Skip to main content
Springer logoLink to Springer
. 2021 May 13;40(12):2623–2626. doi: 10.1007/s10096-021-04268-5

Cryptococcal infection of the colon in a patient without concurrent human immunodeficiency infection: a case report and literature review

Alvaro Quincho-Lopez 1, Noah Kojima 2,, John M Nesemann 3, Rogger Verona-Rubio 4, Dina Carayhua-Perez 5
PMCID: PMC8590644  PMID: 33987802

Abstract

Cryptococcosis is a fungal infection that is rarely reported in patients without human immunodeficiency virus (HIV) infection, especially when the central nervous system (CNS) or pulmonary system is not involved. We report a case of isolated colonic cryptococcosis without disseminated disease in a 64-year-old immunocompetent woman without HIV infection who presented with chronic diarrhea and no episodes of fever or weight loss. The diagnosis was based on histopathology examination. Furthermore, we performed a literature review showing that few reports have been published so far and in the case of colonic cryptococcal infection, the prognosis is favorable among HIV-uninfected patients.

Keywords: Cryptococcal infection, Colon, Non-HIV

Introduction

Cryptococcus spp. are the causative agents of cryptococcosis, a fungal infection that occurs worldwide. Cryptococcosis is one of the leading causes of death among immunosuppressed individuals, especially among those infected with human immunodeficiency virus (HIV) [1]. Although Cryptococcus neoformans causes more than 90% of cryptococcal infections, Cryptococcus gattii affects a greater proportion of immunocompetent individuals, and has a high prevalence in Latin America [1, 2].

Cryptococcus spp. can infect the central nervous system (CNS) and the pulmonary system; however, it can spread to any organ system, especially among cases of severe immunosuppression. Despite this ability to infect any organ system, colonic cryptococcosis that spares other digestive organs is rare, especially among immunocompetent persons [2].

Herein, we report a case of isolated colonic cryptococcosis without disseminated disease in an immunocompetent patient without HIV infection. Additionally, we performed a literature review of other cases of cryptococcosis that have involved the colon, either individually or as part of a disseminated disease, among non-HIV-infected patients.

Case presentation

A 64-year-old woman with a history of high-grade medullary thyroid carcinoma and untreated asthma presented to the Arzobispo Loayza Hospital in Lima, Peru with a chief complaint of 5 months of intermittent chronic diarrhea. She also reported sporadic diffuse abdominal pain that occurred 1 month ago, rectal bleeding, and a painful ano-rectal mass, without fever or weight loss.

On admission, her heart rate was 89 beats/min, respiratory rate of 15 breaths/min, blood pressure of 115/80 mm Hg, temperature of 37.6°C, and her oxygen saturation was 98%. On physical examination, her abdomen was symmetric, soft, and non-tender without distention. Bowel sounds were present. No masses, hepatomegaly, or splenomegaly were noted. On the left side of her thyroid, a painless mass without lymphadenopathy was noted. Laboratory results were as follows: hemoglobin: 12.5 g/dL; WBC: 6160 cell/mm3 with 12% eosinophils (absolute eosinophil count, 739); platelets: 317,000/mm3; total proteins: 7.5 g/dL; albumin: 4.3 g/dL; INR: 0.9; basal glycemia: 97 mg/dL; glycosylated hemoglobin: 5.5%. ELISA HTLV-1 and ELISA HIV-1 were non-reactive. In addition to serologic testing, the HIV RNA assay was negative. Serum creatinine and liver function tests were normal. Chest radiography was negative for nodules, hilar lymphadenopathy, and pleural effusions.

A colonoscopy was performed and described segmental erosive sigmoiditis (Fig. 1a). In the sigmoid colon, 30 cm from the anal margin, a congestive and eroded mucosa was evident on the fold, with loss of the submucosal vascular pattern that compromises 60% of the circumference, not more than 2 cm in length. Grade III internal hemorrhoids were also observed.

Fig. 1.

Fig. 1

a Colonoscopy: Erythematous area is observed with the presence of small diffuse erosions circumscribed by normal mucosa in the central part of the haustra in the sigmoid colon. b Hematoxylin and eosin (H&E) stain shows a foreign body granuloma and multinucleated giant cells phagocytizing intracellular spherical structures that measure between 3 and 15 μm surrounded by a capsule of variable thickness that corresponds to Cryptococcus spp. (at magnification of ×400). c Periodic acid-Schiff (PAS) stain shows a conglomerate of histiocytes containing intracytoplasmic spherical structures corresponding to Cryptococcus spp. (at magnification of ×100)

Histopathological examination of the colonic tissue using hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) staining (Fig. 1b and 1c, respectively) revealed superficial mucosa with moderate acute and chronic inflammatory infiltrate, presence of granulomas, with multinucleated giant cells and PAS-positive thick-walled ovoid structures, consistent with Cryptococcus spp. Serum latex agglutination test for cryptococcal antigen (CrAg) was non-reactive. Further workup such as blood culture and cerebrospinal fluid (CSF) examination through lumbar puncture was negative for fungal or bacterial infection, being the patient diagnosed as an isolated colonic cryptococcosis case without disseminated disease. She started antifungal therapy with fluconazole 400 mg/day for 6 months with clinical improvement.

Discussion

The diagnosis of cryptococcosis is based on the direct visualization of the fungus with an India ink stain, culture of biological samples such sputum or CSF, histopathologic staining of tissues, or serological tests that detect the presence of the cryptococcal polysaccharide capsular antigen (CrAg) [1, 2]; the latex agglutination test and lateral flow assay (LFA) can be used in both serum and CSF samples [3, 4]. Our patient serological assays were non-reactive, so we chose to obtain a biopsy for histologic diagnosis.

Few cases of HIV-negative colonic cryptococcal infection have been published so far; we found 12 case reports in our literature review (Table 1). In these cases, a majority of the patients were female (58.3%; 7/12) and 66.6% (8/12) had a comorbidity, the most common of which was Crohn’s disease (25%; 3/12), which is often treated with immunosuppression [11, 12, 15]. The other 4 patients presented without any comorbidities [6, 9, 10, 16]. Diarrhea was the most frequent presenting symptom, occurring in 50% of the patients [6, 1113, 15, 16], followed by abdominal pain (41.6%; 5/12) [6, 11, 12, 15, 16], and fever (33.3%; 4/12) [8, 11, 12, 15]. These three symptoms occurred simultaneously in 25% (3/12) of the reported cases [11, 12, 15]. Only one patient was asymptomatic on presentation and was diagnosed incidentally [14]. The ascending colon was affected in 41.6% (5/12) of the cases [5, 7, 10, 14, 15]. The types of lesions observed during colonoscopy were ulcers [5, 1115] and masses [68, 10, 15], in 50% (6/12) and 41.6% (5/12) of the patients, respectively. Disseminated disease (> 1 noncontiguous site) was found in four (33.3%; 4/12) patients: one in skin [8], one in lungs [15], and two in the CNS [5, 11]. Amphotericin B (AmB) plus fluconazole (FCZ) was the preferred therapy in 33.3% (4/12) of the cases [10, 13, 16], and all cases that received this treatment improved clinically; 16% (2/12) of patients received AmB plus flucytosine (5FC) [8, 11], with mixed results, as one patient died (8.3%; 1/12); the rest of the cases were managed with FCZ monotherapy (8.3%; 1/12) [9], or surgery plus AmB (16.6%; 2/12) [6, 7], all with favorable results. There were two (16.6%; 2/12) deaths, one from respiratory failure [5] and another from multiple organ failure [8].

Table 1.

Colonic cryptococcal infection case reports in non-HIV patients

Reference Sex/age (years) Underlying conditions Clinical presentation Type of lesion Colonic distribution Another organ involvement Treatment Outcome
Zelman [5] M/25 CML, chemotherapy NR Ulcer Ascending and transverse colon CNS and visceral infiltration None Died
Unat [6] M/16 None Abdominal pain, diarrhea, LGIB Mass Descending colon No Sx + AmB Resolved
Hutto [7] F/29 Job’s syndrome Chronic perirectal abscess Stricture, mass Ascending colon, perirectal area No Sx + AmB Resolved
Daly [8] M/63 Cirrhosis, splenectomy, corticosteroids Fever, chills, peritonitis, skin lesions Mass Transverse colon Skin and omentum AmB + 5FC Died
Melato [9] F/84 None Rectal bleeding Pedunculated polyp Sigmoid colon No Polypectomy Resolved
Song [10] F/27 None Melena Mass Ascending colon No AmB + FCZ Resolved
Osawa [11] M/53 Silicosis, Crohn’s disease (INX, prednisone, AZA) Fever, abdominal pain, and diarrhea Ulcer Cecum CNS AmB + 5FC Resolved
Sciaudone [12] F/26 Crohn’s disease Abdominal pain, fever, diarrhea, melena, weight loss Ulcer, patchy lesions Sigmoid colon, transverse colon, and cecum NR FCZ Resolved
Cicora [13] F/59 Hypertension, Chagas disease, and kidney transplant Diarrhea Ulcer NS NR AmB + FCZ Resolved
Túlio [14] M/70 Madelung disease, hypertension, diabetes, adenocarcinoma (pancreas) None Ulcer, stricture Ascending colon No NR NR
Chavapradit [15] F/58 Crohn’s disease (prednisolone, AZA, MZ) Abdominal pain, fever, and diarrhea Ulcer, mass Ascending colon, ileocecal valve Lungs AmB + FCZ Resolved
Medina Alvarez [16] F/57 None Abdominal pain, diarrhea, hematochezia Nodular lesions From rectum to descending colon NR AmB + FCZ Resolved

Note. AmB amphotericin B; AZA azathioprine; CML chronic myeloid leukemia; CNS central nervous system; FCZ fluconazole; F feminine; INX infliximab; L lower gastrointestinal bleeding; M masculine; MZ mesalazine; NR not reported; NS not specified; Sx surgery; 5-FC flucytosine

In a more general review of fungal infections in the colon, 77% of cryptococcosis occurred in immunosuppressed patients (either with HIV infection or on immunosuppressive therapy), and more than half developed disseminated disease [17]. Although many of the symptoms it produces are general, the most specific is perirectal abscess [7], Cryptococcus spp. being the only fungus that invades the perirectal area [17].

According to the 2010 Infectious Diseases Society of America (IDSA) clinical practice guidelines, for non-disseminated cryptococcal disease that does not involve the CNS or lungs, 400 mg of oral fluconazole per day for 6-12 months is recommended [18]. Although overall response to antifungal therapy is variable, all reports of patients without HIV infection or disseminated disease demonstrate favorable response to treatment [17]. This is consistent with our review of the literature, since only two patients [5, 8], both with disseminated disease, passed away. This suggests that regardless of the treatment received, the prognosis is generally favorable among patients without HIV infection.

Some limitations that we must emphasize are that the patient was not further screened for primary immunodeficiencies and only some of the most common secondary immunodeficiencies (i.e., diabetes, malnutrition) were ruled out.

Clinicians should be aware that cryptococcal infection can occur among immunocompetent patients without neurologic or systemic compromise. Here we described an unusual case of a patient presenting with chronic diarrhea. Histopathological diagnosis is essential, even more so if serological methods are non-reactive, as in our case. Among HIV-uninfected patients, the diagnosis is usually late, although in the case of colonic infection, the prognosis is favorable.

Author contribution

AQL, RVR, and DCP contributed to acquisition of data and permissions. AQL and JMN contributed to drafting of the manuscript. NK contributed to critical revision of the final version. All authors approved the final version of the manuscript.

Availability of data and material

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Code availability

Not applicable.

Declarations

Ethics approval

Ethics approval for this study was waived by the local ethics committee at Universidad Nacional Mayor de San Marcos because it is a single-case study.

Consent to participate

Written informed consent was obtained from the patient.

Consent for publication

The participant has consented to the submission of the case report to the journal.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.May RC, Stone NRH, Wiesner DL, Bicanic T, Nielsen K. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol. 2016;14:106–117. doi: 10.1038/nrmicro.2015.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin N Am. 2016;30:179–206. doi: 10.1016/j.idc.2015.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Binnicker MJ, Jespersen DJ, Bestrom JE, Rollins LO. Comparison of four assays for the detection of cryptococcal antigen. Clin Vaccine Immunol. 2012;19:1988–1990. doi: 10.1128/CVI.00446-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Huang HR, Fan LC, Rajbanshi B, Xu JF. Evaluation of a new cryptococcal antigen lateral flow immunoassay in serum, cerebrospinal fluid and urine for the diagnosis of cryptococcosis: a meta-analysis and systematic review. PLoS One. 2015;10:1–10. doi: 10.1371/journal.pone.0127117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zelman S, O’Neil R, Plaut A. Disseminated visceral torulosis without nervous system involvement with clinical appearance of granulocytic leukemia. Am J Med. 1951;11:658–664. doi: 10.1016/0002-9343(51)90098-8. [DOI] [PubMed] [Google Scholar]
  • 6.Unat E, Pars B, Kosyak J. A case of cryptococcosis of the colon. Br Med J. 1960;2:1501–1502. doi: 10.1136/bmj.2.5211.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hutto JO, Bryan CS, Greene FL, White CJ, Gallin JI. Cryptococcosis of the colon resembling Crohn’s disease in a patient with the hyperimmunoglobulinemia E-recurrent infection (Job’s) syndrome. Gastroenterology. 1988;94:808–812. doi: 10.1016/0016-5085(88)90257-0. [DOI] [PubMed] [Google Scholar]
  • 8.Daly J, Porter K, Chong F, Robillard R. Disseminated, nonmeningeal gastrointestinal cryptococcal infection in an HIV-negative patient. Am J Gastroenterol. 1990;85:1421–1424. [PubMed] [Google Scholar]
  • 9.Melato M, Gorji N. Primary intestinal cryptococcosis mimicking adenomatous polyp in an HIV-negative patient. Am J Gastroenterol. 1998;93:1592–1593. doi: 10.1111/j.1572-0241.1998.00492.x. [DOI] [PubMed] [Google Scholar]
  • 10.Song JC, Kim SK, Kim ES, Jung IS. A case of colonic cryptococcosis. Korean J Gastroenterol. 2008;52:255–260. [PubMed] [Google Scholar]
  • 11.Osawa R, Singh N. Colitis as a manifestation of infliximab-associated disseminated cryptococcosis. Int J Infect Dis. 2010;14:e436–e440. doi: 10.1016/j.ijid.2009.05.019. [DOI] [PubMed] [Google Scholar]
  • 12.Sciaudone G, Pellino G, Guadagni I, Somma A, D’Armiento FP, Selvaggi F. Disseminated Cryptococcus neoformans infection and Crohn’s disease in an immunocompetent patient. J Crohn's Colitis. 2011;5:60–63. doi: 10.1016/j.crohns.2010.08.003. [DOI] [PubMed] [Google Scholar]
  • 13.Cicora F, Petroni J, Roberti J. Cryptococcosis presenting as a colonic ulcer in a kidney transplant recipient: a case report. Transplant Proc. 2015;47:2786–2787. doi: 10.1016/j.transproceed.2015.09.041. [DOI] [PubMed] [Google Scholar]
  • 14.Túlio MA, Figueiredo P, Cassis J. Rare cause for a colonic ulcerated stricture. Gastroenterology. 2017;152:e5–e6. doi: 10.1053/j.gastro.2016.11.009. [DOI] [PubMed] [Google Scholar]
  • 15.Chavapradit N, Angkasekwinai N. Disseminated cryptococcosis in Crohn’s disease: a case report. BMC Infect Dis. 2018;3:1–5. doi: 10.1186/s12879-018-3553-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Medina Alvarez J, Tanta Chipana C, Arévalo Suarez F. Proctocolitis by cryptococcus in an immunocompetent patient: first report in Peru. Rev Gastroenterol Peru. 2019;39:288–291. [PubMed] [Google Scholar]
  • 17.Praneenararat S. Fungal infection of the colon. Clin Exp Gastroenterol. 2014;7:415–426. doi: 10.2147/CEG.S67776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Perfect JR, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291–322. doi: 10.1086/649858. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Not applicable.


Articles from European Journal of Clinical Microbiology & Infectious Diseases are provided here courtesy of Springer

RESOURCES